Prof. Dr. med. Arndt Hartmann

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

COVID-19 effects on the kidney. (2021) Amann KU, Boor P, Wiech T, Singh J, Vonbrunn E, Knöll A, Hermann M, et al. Journal article, Review article Multi-Prototype Few-shot Learning in Histopathology (2021) Deuschel J, Firmbach D, Geppert CI, Eckstein M, Hartmann A, Bruns V, Kuritcyn P, et al. Conference contribution Renal cell tumor with sex-cord/gonadoblastoma-like features: analysis of 6 cases (2021) Wang G, Amin MB, Grossmann P, Ptakova N, Hayes M, Hartmann A, Agaimy A, et al. Journal article Correction to: Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases (Modern Pathology, (2021), 10.1038/s41379-021-00923-6) (2021) Farcaş M, Gatalica Z, Trpkov K, Swensen J, Zhou M, Alaghehbandan R, Williamson SR, et al. Journal article, Erratum Erratum to: Eosinophilic, solid, and cystic renal cell carcinoma (ESC-RCC) (Der Pathologe, (2021), 42, 6, (565-570), 10.1007/s00292-021-00998-7) Erratum zu: Eosinophiles solide und zystisches Nierenzellkarzinom (ESC-NZK) (Der Pathologe, (2021), 42, 6, (565-570), 10.1007/s00292-021-00998-7) (2021) Hartmann A, Agaimy A Journal article, Erratum Undifferentiated and dedifferentiated urological carcinomas: lessons learned from the recent developments (2021) Agaimy A, Hartmann A, Trpkov K, Hes O Journal article, Review article Eosinophiles solide und zystisches Nierenzellkarzinom (ESC-NZK) (2021) Hartmann A, Agaimy A Journal article, Review article The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer (2021) Sikic D, Taubert H, Breyer J, Eckstein M, Weyerer V, Keck B, Kubon J, et al. Journal article Utility of stromal tumor infiltrating lymphocyte scoring (sTILs) for risk stratification of patients with muscle-invasive urothelial bladder cancer after radical cystectomy (2021) Sikic D, Weyerer V, Geppert CI, Bertz S, Lange F, Taubert H, Wach S, et al. Journal article High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer (2021) Sikic D, Eckstein M, Weyerer V, Kubon J, Breyer J, Roghmann F, Kunath F, et al. Journal article